Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories to Present at September Conferences

WILMINGTON, Mass.--(BUSINESS WIRE)--Sept. 2, 2004--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that management will present at two conferences in September 2004.

On Thursday, September 9th, at 10:00 a.m. EDT, Chairman, President and Chief Executive Officer James C. Foster will present at the Thomas Weisel Healthcare Tailwinds 2004 Conference in Boston.

On Tuesday, September 14th, at 9:30 a.m. EDT, James C. Foster and Senior Vice President and Chief Financial Officer Thomas F. Ackerman will present at the Bear Stearns 17th Annual Healthcare Conference in New York.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay for each conference will be accessible through the same website approximately three hours after the presentation and will remain available for one week after the presentation date.


    CONTACT: Charles River Laboratories International, Inc.
             Investor Relations Contact:
             Susan E. Hardy, 978-658-6000 Ext. 1616

    SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)